Classification
Product TypeIngredient
Product FormEnzyme preparation (powder or liquid)
Industry PositionFood processing aid / ingredient
Market
Proteases in Great Britain are primarily used as food enzyme preparations to support industrial food manufacturing processes (for example, protein modification and process performance). Market access is shaped by Great Britain’s regulated products framework overseen by the Food Standards Agency (FSA) and Food Standards Scotland (FSS). FSA guidance indicates that an online register for authorised food enzymes has not yet been established, increasing the need for robust due diligence against applicable food law and regime criteria. As an industrial ingredient, demand is tied to manufacturing activity rather than agricultural seasonality, and products are typically supplied through specialist ingredient distributors to food manufacturers.
Market RoleImport-dependent industrial ingredient market
Domestic RoleIndustrial input for food manufacturing (processing aid / ingredient)
SeasonalityYear-round availability typical for industrial enzyme preparations; demand is driven by food manufacturing production schedules.
Specification
Physical Attributes- Declared enzyme activity (application-specific activity units) and functional specificity (e.g., endo-/exo-protease behavior) are central buyer specifications.
- Powder dustiness/particle handling characteristics matter for workplace exposure control and accurate dosing in production.
Compositional Metrics- Total organic solids (TOS) / activity-to-carrier ratios are commonly used in technical dossiers to describe enzyme preparation strength and standardisation.
Grades- Application-grade specifications typically differentiate by activity range and intended process (e.g., bakery, dairy, brewing, protein processing).
Packaging- Powders commonly supplied in sealed multi-wall bags or drums; liquids commonly supplied in drums or intermediate bulk containers (IBCs), depending on formulation stability and customer dosing systems.
Supply Chain
Value Chain- Enzyme producer (often fermentation-based) → formulation/standardisation into enzyme preparation → GB importer/distributor → buyer technical approval & incoming QC → use as processing aid/ingredient in food manufacturing
Temperature- Avoid excessive heat and moisture to protect enzyme activity during storage and transport; follow supplier shelf-life and storage instructions.
Shelf Life- Shelf life is driven by activity retention over time and is sensitive to storage temperature and moisture exposure for powders.
Freight IntensityLow
Transport ModeMultimodal
Risks
Regulatory Compliance HighFood enzyme market access in Great Britain can be disrupted by uncertain authorisation/listing status and dossier gaps: FSA guidance notes that online registers for authorised food enzymes are not yet established, increasing the compliance burden to demonstrate that protease enzyme preparations meet applicable food law and regime criteria before being placed on the GB market.Pre-qualify each protease preparation against GB regulated products guidance; maintain a complete technical dossier (including manufacturing and specification data) aligned to recognised evaluation expectations, and obtain written buyer/regulatory alignment before shipment.
Occupational Health MediumProtease powders/aerosols can act as workplace allergens and cause respiratory symptoms in exposed workers, creating compliance and operational risk for GB importers, blenders, and food manufacturers handling enzyme preparations.Implement COSHH-based controls (closed transfer/dosing where feasible, local exhaust ventilation, housekeeping, PPE, and health surveillance/monitoring where appropriate).
Food Safety MediumCross-contact and allergenicity concerns (including potential sensitisation) and impurities/specification non-conformance can trigger buyer rejection or corrective actions in GB food manufacturing supply chains.Use lot-based CoA verification and supplier quality agreements; align on allergen and GMO statements where relevant to customer requirements.
Logistics LowWhile freight intensity is generally low for enzymes, border delays and documentation errors can interrupt supply to manufacturers operating lean inventories, increasing the risk of production disruption.Use customs-broker pre-clearance checks (commodity code, origin evidence if claiming preference) and maintain safety stock for critical SKUs.
Sustainability- GMO-related transparency: many industrial enzymes are produced using microbial fermentation (sometimes involving genetically modified production strains), which can drive customer scrutiny and documentation requirements in GB/EU-aligned supply chains.
Labor & Social- Occupational exposure: industrial enzymes (including proteases) can cause allergic reactions and respiratory symptoms in workers if dust/aerosol exposure is not controlled; COSHH-aligned controls and monitoring are relevant in GB workplaces.
Standards- BRCGS
- FSSC 22000
- ISO 22000
- HACCP
FAQ
Do protease food enzymes need market authorisation in Great Britain?Food enzymes fall under Great Britain’s regulated products framework overseen by the Food Standards Agency (FSA) and Food Standards Scotland (FSS). FSA guidance notes that online registers for authorised food enzymes are not yet established; until registers are in place, products may be placed on the market if they meet General Food Law and the relevant criteria in the food enzyme legislation, so suppliers typically need strong dossiers and buyer/regulatory alignment.
What is the biggest trade-stopping risk for protease enzyme preparations in Great Britain?Regulatory compliance and dossier completeness are the main trade-stoppers: because the GB register for authorised food enzymes is not yet established, importers and buyers may reject products if the protease preparation’s regulatory status, specifications, or supporting documentation are not clearly aligned with applicable GB requirements.
Why do GB workplaces treat proteases as a labor/health risk?Industrial enzymes, including proteases, can cause allergic reactions and respiratory symptoms in workers if exposure is not controlled. In Great Britain, this is managed through COSHH-style controls such as containment, ventilation, PPE, and appropriate monitoring/health surveillance where needed.